History
  • No items yet
midpage
223 A.3d 295
Pa. Commw. Ct.
2019
Read the full case

Background

  • Claimant injured his left knee in August 2014; treating physician prescribed medications dispensed by Keystone Rx (Pharmacy) in May 2017.
  • Insurer requested utilization review (UR) in June 2017; the August 2017 UR found all treatment from November 2, 2016 onward unreasonable and unnecessary.
  • Pharmacy filed two fee-review applications (July 2017); the Medical Fee Review Section initially ordered payment for the compound cream and Naprelan tablets.
  • Insurer sought a hearing to contest payment; the Fee Review Hearing Office vacated the administrative determinations and dismissed Pharmacy’s applications, relying on the UR finding.
  • Pharmacy appealed, arguing due process violations and relying on Armour decisions; the Commonwealth Court affirmed dismissal but announced a prospective rule requiring notice and an opportunity to intervene in future URs for non-"health care provider" vendors (e.g., pharmacies, testing labs, supply providers).

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether a UR determination that treatment is unreasonable/unnecessary can defeat a pharmacy's fee-review claim when the pharmacy did not participate in UR Pharmacy: UR outcome cannot deprive it of right to challenge timeliness/amount; Armour I protects provider payment rights and requires due process Insurer: UR process determines reasonableness/necessity and is binding; fee review is limited to amount/timeliness, not medical necessity Court: UR determination is controlling for reasonableness; fee review cannot relitigate UR findings; affirmed dismissal
Whether Armour I/II require reversal or expand fee-review jurisdiction to adjudicate UR validity or provider status Pharmacy: Relies on Armour I/II to argue due process and payment entitlement despite UR Insurer: Armour decisions do not expand fee-review scope beyond amount/timeliness; Hearing Office lacks authority to decide UR merits Court: Distinguished Armour I (involved C&R and an unappealed favorable UR); Armour II confirmed Hearing Office may decide provider status but does not allow determination of medical necessity; created prospective rule requiring notice/opportunity to intervene in UR for non-health-care providers

Key Cases Cited

  • Armour Pharmacy v. Bureau of Workers' Compensation Fee Review Hearing Office, 192 A.3d 304 (Pa. Cmwlth. 2018) (holds C&R cannot deprive nonparty provider of payment and emphasizes due process protections)
  • Armour Pharmacy v. Bureau of Workers' Compensation Fee Review Hearing Office, 206 A.3d 660 (Pa. Cmwlth. 2019) (en banc) (holds Hearing Office may decide provider status but does not expand fee-review power to decide medical necessity; directs holding fee review until UR completes)
Read the full case

Case Details

Case Name: Keystone Rx LLC v. Bureau of WC Fee Review Hearing Office (Compservices Inc./AmeriHealth Casualty Services)
Court Name: Commonwealth Court of Pennsylvania
Date Published: Dec 12, 2019
Citations: 223 A.3d 295; 1369 C.D. 2018
Docket Number: 1369 C.D. 2018
Court Abbreviation: Pa. Commw. Ct.
Log In
    Keystone Rx LLC v. Bureau of WC Fee Review Hearing Office (Compservices Inc./AmeriHealth Casualty Services), 223 A.3d 295